Ensuring Safe Weight Loss for Cardiovascular Risk Patients

Introducing Angelic Lift’s comprehensive FDA-approved approach to supporting safe weight loss

This week marks an exciting announcement from leading health and wellness provider, Angelic Lift, of the introduction and availability of their comprehensive FDA-approved approach to weight loss for cardiovascular risk patients. An integral group that was often overlooked within the world of medical weight loss, cardiovascular risk patients can now safely and effectively lose weight with an FDA-approved approach at Angelic Lift.

This safe and effective weight loss program is completed with the support of the FDA-approved GLP-1 indicated medication, Wegovy. This once-per-week injectable weight loss medication is a well-known alternative to Ozempic, offering the same amazing benefits such as weight loss and reduction of risk for certain cardiovascular events.

“Wegovy is truly an industry-changing innovation within the world of medical weight loss, specifically for our cardiovascular patients,” says Dr. Tinuade Olusegun of Angelic Lift. “This medication not only supports safe and effective weight loss, but also helps to reduce the risk of cardiovascular events like heart attacks or strokes.”

In addition to utilizing the FDA-approved weight loss medication Wegovy as a part of a comprehensive weight loss program, Angelic Lift also focuses on a safe and slow taper of medication for their patients. Their team of experts works closely with each patient on an individual basis to start them on the right initial dose and build them to their proper dose without the risk of negative side effects.

“We start all of our patients on the lowest dose of Wegovy when they begin one of our programs,” says XX of Angelic Lift. “Once we confirm that they can tolerate the medication at this dose and don’t experience any adverse effects, we will slowly increase the dosage to the adequate level to support their needs.”

When patients work with the expert team at Angelic Lift to lose weight with Wegovy, they will begin to lose approximately 5-8% of their body weight per month without the need to make any drastic lifestyle changes. However, this number can be directly affected by diet and activity levels, with patients who regularly exercise reporting a higher level of weight loss. As patients lose weight and move more, they also lower their cardiovascular risk.

It is through their patient dedication and focus on overall health and wellness that Angelic Lift is making waves in the industry. With a commitment to the individual patient and use of FDA-approved weight loss medications, Angelic Lift is quickly proving to be a fantastic resource for cardiovascular risk patients who are interested in losing weight. With both in-person and telehealth appointments available, cardiovascular risk patients can easily take the first step towards bettering their health with Angelic Lift.

Scroll to Top